Erratum to: Fertility preservation with ovarian stimulation and time to treatment in women with stage II-III breast cancer receiving neoadjuvant therapy

Affiliations

¹ Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 1600 Divisadero St., Box 1710, San Francisco, CA, 94115, USA. jo.chien@ucsf.edu.
² University of California San Francisco School of Medicine, Francisco, CA, USA.
³ Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 1600 Divisadero St., Box 1710, San Francisco, CA, 94115, USA.
⁴ Columbia University College of Physicians and Surgeons, New York, NY, USA.
⁵ Department of Obstetrics, Gynecology and Reproductive Sciences, University of California San Francisco, San Francisco, CA, USA.

Published Erratum

A Jo Chien et al. Breast Cancer Res Treat. 2017 Aug.

. 2017 Aug;165(1):161.

doi: 10.1007/s10549-017-4350-1.

¹ Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 1600 Divisadero St., Box 1710, San Francisco, CA, 94115, USA. jo.chien@ucsf.edu.
² University of California San Francisco School of Medicine, Francisco, CA, USA.
³ Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 1600 Divisadero St., Box 1710, San Francisco, CA, 94115, USA.
⁴ Columbia University College of Physicians and Surgeons, New York, NY, USA.
⁵ Department of Obstetrics, Gynecology and Reproductive Sciences, University of California San Francisco, San Francisco, CA, USA.

No abstract available

Erratum for

Fertility preservation with ovarian stimulation and time to treatment in women with stage II-III breast cancer receiving neoadjuvant therapy.
Chien AJ, Chambers J, Mcauley F, Kaplan T, Letourneau J, Hwang J, Kim MO, Melisko ME, Rugo HS, Esserman LJ, Rosen MP. Chien AJ, et al. Breast Cancer Res Treat. 2017 Aug;165(1):151-159. doi: 10.1007/s10549-017-4288-3. Epub 2017 May 13. Breast Cancer Res Treat. 2017. PMID: 28503722 Clinical Trial.